Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:08:50.031Z.
Calculation as of: 2026-10-06T16:08:50.031Z.
Quote observation: 2026-10-06T16:05:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cfadd87817ab9e0f0725aca527bf69eaa76c8d0ff583b2c20c0f03a80ea5973c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-07-28.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Minerva Neurosciences, Inc.
Market Cap
$159.33M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$159.28M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$164.54M
EV/EBIT Ratio
N/A
TTM Avg
8.53x
3Y Avg
141.14x
5Y Avg
141.14x
Market Cap
$165.88M
EV/EBIT Ratio
14.28x
TTM Avg
19.02x
3Y Avg
19.02x
5Y Avg
327.42x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $159.33M | N/A | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $159.28M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $158.32M | N/A | 189.93x | 95.49x | 94.46x |
| PepGen Inc. (PEPG)vs › | $162.20M | N/A | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $154.07M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | N/A | 8.53x | 141.14x | 141.14x |
| Quanterix Corporation (QTRX)vs › | $164.64M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.74M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.88M | 14.28x | 19.02x | 19.02x | 327.42x |
| Codexis, Inc. (CDXS)vs › | $151.12M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2021-07-28 | 0.23x |
| 2021-07-26 | 0.10x |
| 2021-07-23 | 0.42x |
| 2021-07-22 | 0.81x |
| 2021-07-21 | 1.20x |
| 2021-07-20 | 0.94x |
| 2021-07-19 | 0.62x |
| 2021-07-16 | 0.36x |
| 2021-07-15 | 0.94x |
| 2021-07-14 | 0.88x |
| 2021-07-13 | 1.26x |
| 2021-07-12 | 2.17x |
| 2021-07-09 | 2.43x |
| 2021-07-08 | 2.43x |
| 2021-07-07 | 2.81x |
| 2021-07-06 | 2.88x |
| 2021-07-02 | 2.88x |
| 2021-07-01 | 3.01x |
| 2021-06-30 | 2.88x |
| 2021-06-29 | 3.20x |
| 2021-06-28 | 3.46x |
| 2021-06-25 | 3.85x |
| 2021-06-24 | 3.91x |
| 2021-06-23 | 3.78x |
| 2021-06-22 | 3.78x |
| 2021-06-21 | 4.30x |
| 2021-06-18 | 4.88x |
| 2021-06-17 | 5.21x |
| 2021-06-16 | 5.98x |
| 2021-06-15 | 5.98x |
| 2021-06-14 | 7.02x |
| 2021-06-11 | 6.63x |
| 2021-06-10 | 7.73x |
| 2021-06-09 | 7.21x |
| 2021-06-08 | 7.53x |
| 2021-06-07 | 7.47x |
| 2021-06-04 | 6.63x |
| 2021-06-03 | 6.76x |
| 2021-06-02 | 6.95x |
| 2021-06-01 | 7.08x |
| 2021-05-28 | 6.95x |
| 2021-05-27 | 7.02x |
| 2021-05-26 | 7.60x |
| 2021-05-25 | 6.89x |
| 2021-05-24 | 7.47x |
| 2021-05-21 | 7.98x |
| 2021-05-20 | 8.37x |
| 2021-05-19 | 8.37x |
| 2021-05-18 | 10.57x |
| 2021-05-17 | 9.41x |
| 2021-05-14 | 6.82x |
| 2021-05-13 | 5.27x |
| 2021-05-12 | 44.89x |
| 2021-05-11 | 36.95x |
| 2021-05-10 | 38.31x |
| 2021-05-07 | 37.63x |
| 2021-05-06 | 37.40x |
| 2021-05-05 | 40.35x |
| 2021-05-04 | 38.99x |
| 2021-05-03 | 42.40x |
| 2021-04-30 | 40.35x |
| 2021-04-29 | 41.49x |
| 2021-04-28 | 43.08x |
| 2021-04-27 | 43.76x |
| 2021-04-26 | 43.76x |
| 2021-04-23 | 43.76x |
| 2021-04-22 | 43.53x |
| 2021-04-21 | 43.53x |
| 2021-04-20 | 41.04x |
| 2021-04-19 | 41.04x |
| 2021-04-16 | 43.99x |
| 2021-04-15 | 43.31x |
| 2021-04-14 | 41.49x |
| 2021-04-13 | 41.26x |
| 2021-04-12 | 41.26x |
| 2021-04-09 | 46.94x |
| 2021-04-08 | 48.53x |
| 2021-04-07 | 46.26x |
| 2021-04-06 | 48.98x |
| 2021-04-05 | 51.70x |
| 2021-04-01 | 53.75x |
| 2021-03-31 | 52.61x |
| 2021-03-30 | 53.07x |
| 2021-03-29 | 48.07x |
| 2021-03-26 | 52.61x |
| 2021-03-25 | 52.38x |
| 2021-03-24 | 51.48x |
| 2021-03-23 | 54.88x |
| 2021-03-22 | 53.97x |
| 2021-03-19 | 55.56x |
| 2021-03-18 | 56.70x |
| 2021-03-17 | 58.29x |
| 2021-03-16 | 58.51x |
| 2021-03-15 | 61.69x |
| 2021-03-12 | 62.15x |
| 2021-03-11 | 61.01x |
| 2021-03-10 | 56.70x |
| 2021-03-09 | 56.92x |
